Table 2.
Comparison of Erythrocyte Superoxide Dismutase, Catalase Activity, Glutathione, Plasma Malondialdehyde, MMP9 and TNF-α in Non-smokers, Smokers and Patients with Opioids Use Disorder (before MMT)
| Groups |
SOD
(U/mg Hb) |
CAT
(k/mL) |
GSH
(mg/dl) |
MDA
(nM/mL) |
MMP-9
(ng/mL) |
TNF-
α
(pg/mL) |
|---|---|---|---|---|---|---|
| Non-smokers | 25.18±11.25 | 274.22±31.6 | 0.014± 0.005 | 0.085±0.007 | 13.47±1.356 | 40.22±25.8 |
| Smokers | 20.08±10.34 | 216.82±33.4* | 0.0252±0.003 | 0.095±0.022 | 17.21±6.803 | 141.23±96.2* |
| Patients with opioid use disorder (before MMT) |
12.71±10.005* | 224.56±37.7* | 0.0253± 0.009 | 0.10±0.05 | 22.21±6.32* | 199.96±69*,† |
The data are presented as means ± SD.
*
P<0.05 compared to the non-smoker comparison group.
†
P<0.05 compared to the smoker comparison group. Catalase (CAT), Glutathione (GSH), Malondialdehyde (MDA), Superoxide dismutase (SOD), Metalloproteinase-9 (MMP-9) and Tumor Necrosis Factor-α (TNF-α).